Trending News
News
News
Quidel Receives FDA Clearance for its Lyra™ Molecular PCR Assay
A real-time PCR test for the detection of human parainfluenza viruses (HPIV), Types 1, 2 and 3.
News
TGen and NAU Patent for New Pandemic Flu Test is Approved
H1N1 assay benefits patients by helping doctors determine if infections are resistant to available flu treatments.
News
University of Waterloo Awarded Four Canada Research Chairs
New and renewed Canada Research Chair appointments are worth $2.9 million in funding.
News
Head injury causes the immune system to attack the brain
Scientists have uncovered a surprising way to reduce the brain damage caused by head injuries stopping the body's immune system from killing brain cells. The study, published in the open access journal Acta Neuropathologica Communications, showed that in experiments on mice, an immune-based treatment reduced the size of brain lesions.
News
Cold sore virus increases the risk of dementia
Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University claim this in two studies in the journal Alzheimer’s & Dementia.
News
Rapid agent restores pleasure-seeking ahead of other antidepressant action
A drug being studied as a fast-acting mood-lifter restored pleasure-seeking behavior independent of — and ahead of — its other antidepressant effects, in a National Institutes of Health trial.
News
See-through, one-atom-thick, carbon electrodes are a powerful tool for studying epilepsy, other brain disorders, study finds
Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene- a two-dimensional form of carbon only one atom thick- to fabricate a new type of microelectrode that solves a major problem for investigators looking to understand the intricate circuitry of the brain.
News
CRT Introduces Ximbio, an Online Reagents Portal
Ximbio aims to change the way reagents are searched, sourced and shared.
News
SomaLogic Announces Novartis Agreement Extension, Equity Investment
Multi-year research agreement for development and application of SomaLogic’s unique proteomics technology to Novartis’ drug discovery and development efforts.
News
New England Biolabs®, Directed Genomics Partnership
Partnership established to develop novel target enrichment technologies for next generation sequencing.
Advertisement